Sponsor or institution
Clinical trials and research at Chengdu Suncadia Medicine Co., Ltd.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Chengdu Suncadia Medicine Co., Ltd. that are recruiting, in China. By phase: Phase 1 (2), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| HRS-1635 in B-cell cancers: a first-in-human dose study | Phase 1 | Chengdu, Sichuan | Recruiting | May 13, 2026 |
| Long-term safety and tolerability of HRS-5965 in primary IgA nephropathy | Phase 2 | Beijing, Beijing Municipality | Recruiting | May 12, 2026 |
| HRS-5765 tablet safety and pharmacology in healthy adults | Phase 1 | Beijing, Beijing Municipality | Recruiting | Apr 24, 2026 |
| HRS-5965 capsule for primary IgA nephropathy | Phase 3 | Beijing, Beijing Municipality | Recruiting | Jun 11, 2025 |
All recruiting trials (4)
-
HRS-1635 in B-cell cancers: a first-in-human dose study
This early-stage trial tests whether HRS-1635 is safe and tolerable in adults with relapsed or refractory B-cell malignancies, and to find a recommended dose for future studies.
-
Long-term safety and tolerability of HRS-5965 in primary IgA nephropathy
This study tests whether HRS-5965 capsules are safe to use over the long term and whether they can reduce 24-hour urinary protein and slow eGFR decline in adults with primary IgA nephropathy who previously completed or stopped during maintenance.
-
HRS-5765 tablet safety and pharmacology in healthy adults
This first-in-human study tests whether HRS-5765 is safe and well tolerated in healthy adults and how it behaves in the body.
-
HRS-5965 capsule for primary IgA nephropathy
This Phase 3 trial will test whether HRS-5965 capsules reduce proteinuria and are safe for people with biopsy-confirmed primary IgA nephropathy who have persistent proteinuria and eGFR ≥30.
Quick answers
How many clinical trials run by Chengdu Suncadia Medicine Co., Ltd. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.